Details of the Drug Reposition

General Information of This Drug (ID: DMQX5SN)

• Drug Name: LAG525 (DMQX5SN)

Information on Drug Reposition of This Drug

3 Phase 1/2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Solid tumour/cancer	DISZR48F	2A00-2F9Z	Phase 1/2	[1]
Melanoma	DIS1RRCY	2C30	Phase 1/2	[1]
Renal cell carcinoma	DISQZ2X8	2C90	Phase 1/2	[1]

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)